Published: Nov-2022|  Format: PDF | MBI Research |  Number of pages: 140 | Code: MBI-3929636

In-Vitro Fertilization Market Size, Share, Growth & Demand Analysis Report By Product (Fresh Non-Donor, Frozen Donor, Frozen Non-Donor, Fresh Donor) By End-User (Surgical Centers, Hospitals, Research Institutes, Fertility Clinics) Forecast Period 2022-2030

Select a Format




 Buy Now

Market Overview:

The Global In-Vitro Fertilization Market size was valued at USD 20.15 billion in 2021 and is projected to register a valuation of USD 32 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 5.7% over the forecast period 2022-2030. The revenue growth in the in vitro fertilization market is driven by rising infertility rates, owing to the adoption of sedentary lifestyles and medical conditions and diseases. The rise in the incidence of male and female infertility and an increasing number of women in the workforce are other factors propelling the market growth.

In vitro fertilization (IVF) is one of the most widely used assisted reproductive techniques (ART) and works using a combination of both surgical and drug procedures. IVF treatment helps in the development of the embryo and implantation in an infertile couple. IVF is the process of fertilization by retrieving a sample of sperm, extracting eggs, and then mixing the egg and sperm manually in a laboratory.

The adoption of IVF technology has resulted in the birth of approximately half a million children each year using IVF or other assisted reproductive technologies. Thus, the increasing popularity of IVF and ICSI treatment is expected to boost the adoption of in vitro fertilization (IVF) treatment over the forecast period.

Covid-19 Impact Analysis:

The outbreak of COVID-19 and the subsequent extent of the lockdown have impacted the in vitro fertilization market across the globe. As the Covid-19 crisis continues, many global industrial manufacturing companies are facing challenging times including production shutdowns, transportation, supply chain disruptions, cost increases, and workforce disruptions, which have several negative impacts on the global in vitro fertilization industry in terms of revenue.

The COVID-19 pandemic set off a worldwide suspension of in vitro fertilization treatments; It had an intense effect on women undergoing IVF procedures

Driving Factors:

The increasing prevalence of infertility, the growing success rate of IVF procedures, and rising awareness about infertility are some of the key factors that are driving the demand for IVF treatment across the world. Delay in pregnancy after marriage is another important factor fueling the demand of the market. There has been an increase in the number of mothers who delay conception even after the age of 35. Delayed pregnancies lead to complications in pregnancy, which lead to infertility and hence fuel the growth of the in-vitro market.

Restraining Factor:

Despite the positive growth projections, there are some factors that are challenging the growth of the IVF market. Some of these factors include the high cost of IVF treatment, lack of proper reimbursement policies, and declining success rates of IVF treatment procedures in older patients.

Key Market Players:

  • Vitrolife AB
  • The Baker Company, Inc.
  • Kitazato Corporation
  • Cooper Surgical, Inc.
  • Thermo Fisher Scientific Inc.
  • OvaScience
  • Boston IVF
  • Cook Medical, Inc.
  • Esco Micro Pte. Ltd.
  • EMD Serono Inc.

Market Segmentation:

The global in vitro fertilization market is segmented by product type, by application, and region.

By Product

On the basis of product the market is segmented into, Fresh Non-Donor, Frozen Donor, Frozen Non-Donor, and Fresh Donor.

The frozen non-donor segment is expected to dominate the market during the forecast period. This is mainly attributed due to the high pregnancy rate coupled with the low cost. A frozen transfer is much easier for both patients and endocrinologists.

By End-User

On the basis of end-user the market is segmented into, Surgical Centers, Hospitals, Research Institutes, and Fertility Clinics.

The hospital segment is expected to dominate the market during the forecast period. Widespread penetration of hospitals, development of healthcare infrastructure in developing countries, 24/7 presences of healthcare professionals, and availability of advanced surgical instruments and equipment in hospitals are the major factors that drive the demand for hospital services.

Regional Analysis:

The global in vitro fertilization market is categorized into regions such as Latin America, North America, Europe, Asia-pacific, the Middle East, and Africa.

The Asia Pacific region is expected to witness significant growth during the forecast period. This is attributed to the presence of rapidly declining fertility rates, a large population, a growing number of government initiatives focused on women, an increasing preference for careers over the family among the female population, and the awareness of fertility clinics and procedures. Increasing awareness among the people about in-vitro fertilization, increasing healthcare spending, and adoption of advanced reproductive technology in the Asia Pacific are the key drivers of the in-vitro fertilization market.

Report Coverage: 

Market Segmentation:

By Product Type

  • Fresh Non-Donor
  • Frozen Donor
  • Frozen Non-Donor
  • Fresh Donor

By End-User

  • Surgical Centers
  • Hospitals
  • Research Institutes
  • Fertility Clinics

By Region

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa



Inquiry before buying

Request Sample

Request for Discount

Latest News

Global Cancer Immunotherapy Market to Grow at a (CAGR) of 13.9% during the Forecast Period 2022-2030

18-Nov-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the global  Cancer Immunotherapy Market is projected to reach USD 275.5 billion by 2030. Moreover, increasing day-by-day incidence of cancer, increasing awareness about early diagnosis, the effectiveness of thera ...

Global In-Vehicle Infotainment Market to Grow at a (CAGR) of 9.8% during the Forecast Period 2022-2030

17-Nov-2022 | Automobile

As specified in our exclusive report, the global  In-Vehicle Infotainment Market is projected to reach USD 42.25 billion by 2030. In-vehicle infotainment systems provide entertainment and information services to the driver and passengers throughou ...

Global Blockchain in Healthcare Market to Grow at a (CAGR) of 59% during the Forecast Period 2022-2030

16-Nov-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the global Blockchain in Healthcare Market is projected to reach USD 119 billion by 2030. The growing need for curbing these issues along with the increasing incidence of information leaks and data breaches has be ...

Global In Vitro Fertilization Market to Grow at a (CAGR) of 5.7% during the Forecast Period 2022-2030

14-Nov-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the Global In-Vitro Fertilization Market is projected to reach USD 32 billion by 2030. In-vitro fertilization involves some risks such as genetic disease transfer during the pr ...

Global Microfluidics Market to Grow at a (CAGR) of 15.8% during the Forecast Period 2022-2030

11-Nov-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the global  Microfluidics Market is projected to reach USD 61 billion by 2030. The growth in demand for point-of-care (POC) devices is expected to majorly drive the market size in the coming years. Simultaneously demand ...

More News...